A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
The phytoestrogen components of soy may interfere with the drug tamoxifen (Nolvadex), used in breast cancer treatment for men and women, and the drug raloxifene (Evista), used to prevent and treat osteoporosis. The minerals zinc and iron may also interfere with the absorption of soy and could theoretically lower soy levels in the body. Further research is needed.
Soy; Soy isoflavones; Soy protein; Soy protein extract; Soybean
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885